{"id":"oral-contraceptives-cyclic","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Breakthrough bleeding"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"},{"rate":"2-5","effect":"Hypertension"},{"rate":"variable","effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These formulations contain estrogen and progestin in a cyclic dosing pattern, where hormones are taken for 21 days followed by a hormone-free interval. The exogenous hormones inhibit the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), preventing follicle development and ovulation. Additionally, they thicken cervical mucus and alter the endometrium to provide multiple contraceptive mechanisms.","oneSentence":"Cyclic oral contraceptives prevent pregnancy by suppressing ovulation through combined hormonal inhibition of the hypothalamic-pituitary-ovarian axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:39.993Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception / prevention of pregnancy"},{"name":"Menstrual cycle regulation"},{"name":"Treatment of acne (secondary indication)"}]},"trialDetails":[{"nctId":"NCT07127458","phase":"NA","title":"Anxiety and Depression in Adolescent PCOS","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-08-17","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":42},{"nctId":"NCT07229209","phase":"NA","title":"Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-05","conditions":"Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar","enrollment":166},{"nctId":"NCT07419776","phase":"","title":"The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-06-24","conditions":"Poly Cystic Ovary Syndrome","enrollment":90},{"nctId":"NCT03947684","phase":"","title":"Exploring the Modulatory Role of Sex Hormones Along the Neuromechanical Axis in Females","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-04-12","conditions":"Role of Sex Hormones Along the Neuromechanical Axis","enrollment":102},{"nctId":"NCT07340190","phase":"PHASE1","title":"A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Advanced Malignancies","enrollment":24},{"nctId":"NCT07010146","phase":"PHASE2","title":"Role of Estrogen on Skeletal Outcomes in FHA","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)","enrollment":150},{"nctId":"NCT04756037","phase":"PHASE3","title":"Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2021-03-18","conditions":"Contraception","enrollment":1020},{"nctId":"NCT07242131","phase":"NA","title":"Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS","status":"RECRUITING","sponsor":"Ege University","startDate":"2025-12-01","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":150},{"nctId":"NCT07258576","phase":"NA","title":"Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-07-20","conditions":"Female Sex Hormones, Menstrual Cycle, Oral Contraceptives","enrollment":20},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT05264506","phase":"PHASE3","title":"Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2022-02-17","conditions":"Contraception","enrollment":3055},{"nctId":"NCT03819140","phase":"PHASE4","title":"Continuous Versus Cyclical OCP Use in PCOS","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-04-01","conditions":"Polycystic Ovary Syndrome","enrollment":51},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT05461573","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2022-08-02","conditions":"Contraception, Change in Bone Mineral Density","enrollment":1542},{"nctId":"NCT06334315","phase":"PHASE4","title":"Oral Contraceptive Pill (OCP) Pharmacogenomics","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-29","conditions":"Contraception, Pharmacogenomic Drug Interaction","enrollment":700},{"nctId":"NCT07084714","phase":"NA","title":"Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms","status":"RECRUITING","sponsor":"University of Colorado, Colorado Springs","startDate":"2025-07","conditions":"Premenstrual Syndrome, Menstrual Cycle, Menstrual Distress (Dysmenorrhea)","enrollment":35},{"nctId":"NCT05188014","phase":"NA","title":"Exercise and the Menstrual Cycle in Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-03-15","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT06275048","phase":"NA","title":"The Influence of Oral Contraceptives During Disuse","status":"COMPLETED","sponsor":"University of Central Florida","startDate":"2024-01-26","conditions":"Oral Contraceptives, Rehabilitation, Menstrual Cycle","enrollment":41},{"nctId":"NCT03249402","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2017-08-14","conditions":"Healthy","enrollment":24},{"nctId":"NCT06763926","phase":"PHASE4","title":"Intranasal Nafarelin For Triggering Oocyte Maturation","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2025-03-15","conditions":"Fertility Disorders","enrollment":134},{"nctId":"NCT05347667","phase":"NA","title":"Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on Muscle Protein Synthesis","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-05-01","conditions":"Menstrual Cycle, Resistance Exercise, Muscle Protein Synthesis","enrollment":24},{"nctId":"NCT06750172","phase":"","title":"Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-12-15","conditions":"Primary Aldosteronism","enrollment":33},{"nctId":"NCT06310616","phase":"PHASE1","title":"A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2024-03-06","conditions":"HIV Infections","enrollment":26},{"nctId":"NCT05677269","phase":"","title":"The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2023-02-17","conditions":"Endometriosis, Rectum, Endometriosis of Colon, Subfertility, Female","enrollment":339},{"nctId":"NCT06450301","phase":"","title":"Senescent Endometrial Cells in Patients with Thin Endometrial Lining","status":"RECRUITING","sponsor":"Trio Fertility","startDate":"2024-09-11","conditions":"Asherman's Syndrome, Thin Endometrial Lining, Cell Senescence","enrollment":100},{"nctId":"NCT00754065","phase":"PHASE3","title":"To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-09-08","conditions":"Contraception","enrollment":409},{"nctId":"NCT06679491","phase":"NA","title":"Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes","status":"RECRUITING","sponsor":"Universite de La Reunion","startDate":"2024-11-01","conditions":"Menstrual Cycle, Resistance Training, Neuromuscular Function","enrollment":60},{"nctId":"NCT06582654","phase":"","title":"Normalizing Antibody Detection in First-void Urine","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2023-12-07","conditions":"Human Papillomavirus Infection","enrollment":150},{"nctId":"NCT06529952","phase":"NA","title":"Comparative Study Between Hormonal and Hysteroscopic Management of Cesarean Scar Defect","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-02-10","conditions":"Cesarean Scar Defect","enrollment":78},{"nctId":"NCT04205929","phase":"PHASE4","title":"Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2020-04-15","conditions":"Bleeding, Implants, Breakthrough Bleeding","enrollment":58},{"nctId":"NCT01656434","phase":"PHASE3","title":"Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2012-11-02","conditions":"Contraception","enrollment":3173},{"nctId":"NCT06214442","phase":"","title":"Effects of the Menstrual Cycle on Triceps Surae Properties in Women","status":"RECRUITING","sponsor":"Marco Aurélio Vaz, PhD","startDate":"2023-11-10","conditions":"Menstrual Cycle, Achilles Tendon","enrollment":40},{"nctId":"NCT05872425","phase":"NA","title":"Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2023-02-01","conditions":"PCOS","enrollment":120},{"nctId":"NCT02668783","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2016-02-11","conditions":"Moderate to Severe Primary Dysmenorrhea","enrollment":25},{"nctId":"NCT02668822","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2016-02-09","conditions":"Dysmenorrhea","enrollment":18},{"nctId":"NCT06426459","phase":"","title":"Social Media Usage in Adolescent Girls","status":"NOT_YET_RECRUITING","sponsor":"International Research Training Group 2804","startDate":"2024-05-29","conditions":"Menstrual Cycle, Oral Contraceptive","enrollment":70},{"nctId":"NCT02616146","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2015-12-01","conditions":"Contraception","enrollment":2016},{"nctId":"NCT03745144","phase":"PHASE1","title":"Effects of Cladribine Tablets on the PK of Microgynon®","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2019-01-17","conditions":"Relapsing Multiple Sclerosis (RMS)","enrollment":28},{"nctId":"NCT05610527","phase":"NA","title":"Hormonal Influences on Inflammatory Bowel Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2024-12-01","conditions":"Inflammatory Bowel Diseases, Contraception, Menstrual Problem","enrollment":200},{"nctId":"NCT04233762","phase":"","title":"Effect of Sex Hormone During the Menstrual Cycle on Capsaicin Evoked Cough Responses","status":"COMPLETED","sponsor":"McMaster University","startDate":"2020-01-08","conditions":"Asthma","enrollment":32},{"nctId":"NCT05802277","phase":"NA","title":"Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.","status":"UNKNOWN","sponsor":"EZUS-LYON 1","startDate":"2022-10-05","conditions":"Menstrual Cycle, Oral Contraceptive Use","enrollment":130},{"nctId":"NCT06222749","phase":"NA","title":"Oxytocin and Reward Processing in Women","status":"RECRUITING","sponsor":"International Research Training Group 2804","startDate":"2024-02-16","conditions":"Menstrual Cycle, Hormonal Contraception","enrollment":100},{"nctId":"NCT04778527","phase":"NA","title":"A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention","status":"UNKNOWN","sponsor":"Population Council","startDate":"2022-09-13","conditions":"HIV Infections","enrollment":96},{"nctId":"NCT02859337","phase":"PHASE4","title":"Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2017-05-30","conditions":"Obesity, Contraception","enrollment":64},{"nctId":"NCT04778514","phase":"NA","title":"A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention","status":"COMPLETED","sponsor":"Population Council","startDate":"2022-12-07","conditions":"HIV Infections, Contraception","enrollment":30},{"nctId":"NCT04792385","phase":"PHASE3","title":"Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents","status":"COMPLETED","sponsor":"Estetra","startDate":"2020-12-28","conditions":"Safety","enrollment":145},{"nctId":"NCT05683119","phase":"NA","title":"The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2023-09-20","conditions":"Menstrual Cycle, Oral Contraceptives","enrollment":20},{"nctId":"NCT04055129","phase":"","title":"Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control","status":"COMPLETED","sponsor":"University of St. Augustine for Health Sciences","startDate":"2021-11-17","conditions":"Hormone Influence on Ligament Laxity and Motor Control","enrollment":52},{"nctId":"NCT03945513","phase":"PHASE3","title":"A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2019-12-03","conditions":"Contraception","enrollment":1034},{"nctId":"NCT06124274","phase":"NA","title":"Oral Contraceptive vs Menstrual Cycle Ex Vivo Model","status":"UNKNOWN","sponsor":"University of Toronto","startDate":"2023-08-09","conditions":"Contraceptives, Oral, Sex Hormone","enrollment":10},{"nctId":"NCT04396730","phase":"PHASE4","title":"Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2020-04-08","conditions":"Contraception","enrollment":9},{"nctId":"NCT02214550","phase":"PHASE4","title":"Chronic Pain Risk Associated With Menstrual Period Pain","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2014-07","conditions":"Cystitis, Interstitial, Dysmenorrhea, Migraine Disorders","enrollment":353},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT00280657","phase":"PHASE3","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03-10","conditions":"Acne Vulgaris","enrollment":1326},{"nctId":"NCT02912988","phase":"PHASE3","title":"Letrozole in Stimulated IVF Cycles","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-03-01","conditions":"Subfertility","enrollment":900},{"nctId":"NCT03091595","phase":"PHASE2","title":"E4/DRSP Ovarian Function Inhibition Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2017-02-07","conditions":"Prevention of Pregnancy","enrollment":82},{"nctId":"NCT05587920","phase":"","title":"Effect of Oestrogen on Musculoskeletal Outcomes","status":"UNKNOWN","sponsor":"Army Health Branch, British Army","startDate":"2021-12-01","conditions":"Contraception, Estrogen Deficiency, Estrogen Excess","enrollment":100},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome","enrollment":145},{"nctId":"NCT05576740","phase":"","title":"Influence of Menstrual Cycle Stages on Female Athletes","status":"COMPLETED","sponsor":"Universitat Jaume I","startDate":"2022-03-16","conditions":"Menstrual Cycle, Sports","enrollment":41},{"nctId":"NCT05594186","phase":"NA","title":"Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-03-01","conditions":"Intermenstrual Bleeding","enrollment":158},{"nctId":"NCT04665999","phase":"","title":"Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2021-01-15","conditions":"Type 1 Diabetes Mellitus","enrollment":37},{"nctId":"NCT05212389","phase":"NA","title":"The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2021-12-22","conditions":"Major Depressive Disorder, Sexual Behavior, Mood Disturbance","enrollment":40},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT01723579","phase":"PHASE3","title":"Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-07","conditions":"Contraception","enrollment":""},{"nctId":"NCT00413062","phase":"PHASE3","title":"Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06","conditions":"Contraception","enrollment":2281},{"nctId":"NCT00511355","phase":"PHASE3","title":"Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":121},{"nctId":"NCT00511342","phase":"PHASE3","title":"Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Contraception","enrollment":110},{"nctId":"NCT00511433","phase":"PHASE3","title":"Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":48},{"nctId":"NCT00511199","phase":"PHASE3","title":"Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05-01","conditions":"Contraception","enrollment":2152},{"nctId":"NCT01388491","phase":"PHASE2","title":"A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-10-31","conditions":"Hemostasis, Oral Contraceptive","enrollment":293},{"nctId":"NCT00544882","phase":"PHASE3","title":"A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-10-31","conditions":"Healthy","enrollment":61},{"nctId":"NCT02943655","phase":"PHASE3","title":"Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-11-01","conditions":"Improve Quality of Life, Heavy Menstrual Bleeding","enrollment":240},{"nctId":"NCT03717870","phase":"NA","title":"Surgery and ART For Endometrioma","status":"NOT_YET_RECRUITING","sponsor":"Università degli Studi dell'Insubria","startDate":"2023-10","conditions":"Ovarian Endometrioma, Infertility, Female","enrollment":100},{"nctId":"NCT01143844","phase":"","title":"Assessing Fertility Potential in Female Cancer Survivors","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-03","conditions":"Effects of Chemotherapy","enrollment":391},{"nctId":"NCT01058252","phase":"","title":"Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF","status":"UNKNOWN","sponsor":"Galaxy Pharma (Pvt) Limited","startDate":"2021-05","conditions":"Primary Infertility, Secondary Infertility, Low Responders","enrollment":30},{"nctId":"NCT01469585","phase":"NA","title":"Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases","status":"COMPLETED","sponsor":"University of Hawaii","startDate":"2011-11","conditions":"Breakthrough Bleeding","enrollment":20},{"nctId":"NCT02533427","phase":"PHASE1","title":"Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2015-10-29","conditions":"HCV Infection","enrollment":15},{"nctId":"NCT02036879","phase":"EARLY_PHASE1","title":"Gender Disparity and Hormones in Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2014-02","conditions":"Cystic Fibrosis (CF)","enrollment":55},{"nctId":"NCT02903121","phase":"PHASE4","title":"Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2017-01-20","conditions":"Bleeding, Implants, Breakthrough Bleeding","enrollment":109},{"nctId":"NCT04458662","phase":"","title":"Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise","status":"COMPLETED","sponsor":"Universidad Politecnica de Madrid","startDate":"2017-01-01","conditions":"Iron-deficiency, Inflammation, Exercise Induced Iron-deficiency","enrollment":103},{"nctId":"NCT04310683","phase":"NA","title":"Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate","status":"UNKNOWN","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2020-11-10","conditions":"Pre-Eclampsia","enrollment":840},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT04296422","phase":"NA","title":"Different Does of Acupuncture on Premenstrual Syndrome Efficacy Analysis","status":"UNKNOWN","sponsor":"Taipei City Hospital","startDate":"2019-01-01","conditions":"Premenstrual Syndrome","enrollment":105},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT02817841","phase":"PHASE3","title":"E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-08-30","conditions":"Contraception","enrollment":2148},{"nctId":"NCT03301207","phase":"PHASE1","title":"A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-10-20","conditions":"Leukemia, Lymphocytic, Chronic, B-Cell","enrollment":25},{"nctId":"NCT02577601","phase":"PHASE4","title":"Impact of Combined Hormonal Contraceptives on UPA","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2015-09-08","conditions":"Contraception","enrollment":36},{"nctId":"NCT02817828","phase":"PHASE3","title":"E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-06","conditions":"Contraception","enrollment":1577},{"nctId":"NCT03088631","phase":"PHASE2","title":"Metformin in Intracytoplasmic Sperm Injection Cycles","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-03-01","conditions":"Intracytoplasmatic Sperm Injection","enrollment":320},{"nctId":"NCT03581201","phase":"","title":"The Relationship of the Intestinal Microbiome and the Menstrual Cycle","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2018-07-18","conditions":"Sex Hormones, Microbial Colonization","enrollment":20},{"nctId":"NCT02269241","phase":"PHASE3","title":"Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles","status":"COMPLETED","sponsor":"Laboratories Leon Farma, S.A.","startDate":"2014-10-09","conditions":"Contraception","enrollment":1552},{"nctId":"NCT03856970","phase":"PHASE1","title":"Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2019-03-11","conditions":"Healthy Volunteers","enrollment":87},{"nctId":"NCT03783897","phase":"PHASE1","title":"A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects","status":"COMPLETED","sponsor":"Enanta Pharmaceuticals, Inc","startDate":"2018-11-27","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":43},{"nctId":"NCT02710708","phase":"PHASE4","title":"YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-05-27","conditions":"Contraception","enrollment":1921},{"nctId":"NCT01602770","phase":"","title":"Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-02-06","conditions":"Contraception","enrollment":1},{"nctId":"NCT02104609","phase":"","title":"Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2013-04","conditions":"Obesity","enrollment":26},{"nctId":"NCT03881904","phase":"PHASE1, PHASE2","title":"OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2017-06-01","conditions":"Subfertility, Female","enrollment":740},{"nctId":"NCT03210246","phase":"PHASE1","title":"Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-17","conditions":"Clinical Trial ,Phase I","enrollment":71},{"nctId":"NCT02404038","phase":"NA","title":"A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods","status":"UNKNOWN","sponsor":"Desmond Tutu HIV Centre","startDate":"2015-07","conditions":"HIV","enrollment":131},{"nctId":"NCT02792517","phase":"PHASE1","title":"Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females","status":"COMPLETED","sponsor":"Amgen","startDate":"2016-02-12","conditions":"Headache, Migraine","enrollment":41}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":478,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Yasmin."],"phase":"marketed","status":"active","brandName":"Oral contraceptives cyclic","genericName":"Oral contraceptives cyclic","companyName":"University of Athens","companyId":"university-of-athens","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cyclic oral contraceptives prevent pregnancy by suppressing ovulation through combined hormonal inhibition of the hypothalamic-pituitary-ovarian axis. Used for Contraception / Prevention of pregnancy, Menstrual cycle regulation, Treatment of acne (secondary indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}